At Pious Research, we are committed to advancing healthcare through rigorous clinical trials, ensuring the inclusion of diverse patient populations.
Wellness Through Discovery
For Sponsors
Pious Research, brings unmatched expertise and unwavering dedication to embedding diversity in every clinical trial, ensuring that research reflects and serves all communities. With over 30 years of combined experience across Phase 1 to Phase 4 trials, our team offers deep insight from a wide range of medical specialties and roles—including recruitment, project management, clinical monitoring, and sponsor-side operations. We know that meeting deadlines and delivering results are essential to both site performance and the overall success of a clinical trial.
Investigators
Our investigators bring extensive experience in both standard patient care and clinical research, seamlessly integrating trials into their daily practice. They prioritize patient safety and are deeply committed to offering research opportunities that align with the best interests of their patients.
Recruitment Team
Our recruitment team collaborates closely with coordinators, PIs, and Sub-Is in regular meetings to align on patient targeting strategies and ensure unified efforts toward meeting enrollment goals. This team-based approach fosters communication, accountability, and success across every trial.
Coordinators
Our coordinators and staff receive targeted training alongside the Principal Investigator (PI) or Sub-Investigator (Sub-I) specific to the clinical research protocol and its indication. Weekly meetings with the PI ensure consistent oversight, alignment, and proactive support to drive trial success across each trial.
Marketing Diversity
At Pious Research, our goal is to ensure broad diversity among clinical trial participants by actively engaging underrepresented communities. While outreach to these groups can sometimes be challenging, we invest in building trust through consistent collaboration with local healthcare providers, community leaders, churches, and cultural organizations. Guided by compassion and a commitment to giving back, we proudly participate in community events and partner with foundations to stay connected.
Regulatory Team
Startup typically takes 4–6 weeks, with contracts, budgets, and IRB submissions progressing in parallel to streamline the activation process. This coordinated approach helps ensure timely site readiness and trial launch.
Want to Participate in a Clinical Trial?
​At Pious Research, we’re continuously receiving new clinical trials and expanding opportunities for participation. Please submit your information to the email(s) listed at the contact section below, and one of our dedicated recruiters will reach out to gather basic details and match you with current or upcoming studies that may be right for you.
Initial Contact/ PreScreening Visit
During your initial call or Pre-Screening visit, a member of our team will contact you to gather basic demographic and medical information to determine your eligibility for current clinical trials. This process also adds you to our database, allowing us to match you with future research opportunities that best fit your profile.
Screening Visit
At your screening visit, you're encouraged to bring any relevant medical records if you have them. You'll review and sign a consent form specific to the trial, with the study doctor available to answer any questions. A medical records release form will also be signed, and protocol-required assessments—such as bloodwork, EKG, urine collection, or other procedures—will be completed. Please note, no assessments can begin until the consent form is signed.
Enrollment into a Trial
This is known as the study enrollment or baseline visit, where you'll take the study medication for the first time under close supervision of the study doctor and staff. If required by the protocol, fasting may be necessary, and we’ll repeat assessments such as bloodwork, EKG, and urine collection prior to your first dose of study medication. The visit may last up to 4 hours, excluding observation time, and you'll be informed when it's okay to eat and drink.
Our Research Focus
Phase 1b
Phase 2 Trials
We conduct Phase 1b trials to assess safety and dosage, laying the groundwork for effective drug development in diverse populations.
In our Phase 2 trials, we evaluate the effectiveness of treatments, utilizing a diverse participant base to ensure comprehensive data collection.
Phase 3 Trials
During Phase 3 trials, we focus on the comparative effectiveness of new therapies, actively engaging patients from varied backgrounds to enhance study validity.
Phase 4 Trials
Our Phase 4 trials monitor long-term effects and safety, addressing diverse patient needs to optimize health outcomes post-marketing.